We demonstrated that, in distinction to classical opioid receptors, ACKR3 would not induce classical G protein signaling and is not modulated because of the classical prescription or analgesic opioids, like morphine, fentanyl, or buprenorphine, or by nonselective opioid antagonists including naloxone. Instead, we established that LIH383, an ACKR3-selective subnanomolar https://philc162ulb7.anchor-blog.com/profile